• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Inari Medical Inc (NQ: NARI )

    52.00 -1.27 (-2.38%)
    Streaming Delayed Price Updated: 2:38 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Inari Medical Inc

    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Inari Medical, Inc. (NARI) on Behalf of Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    NARI INVESTOR NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    NARI INVESTOR NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
    WHY: NEW YORK, NY - (NewMediaWire) - March 06, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Inari Medical,... 
    Via TheNewswire.com
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    Critical Insights From Inari Medical Analyst Ratings: What You Need To Know
    Via Benzinga
    Recap: Inari Medical Q4 Earnings
    Via Benzinga
    Inari Medical Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
    Via Benzinga
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Inari Medical, Inc. (NARI) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    The Law Offices of Frank R. Cruz Announces Investigation of Inari Medical, Inc. (NARI) on Behalf of Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    INARI MEDICAL (NASDAQ: NARI): Kaplan Fox Encourages Inari Medical, Inc Investors with Significant Losses to Contact the Firm
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    INARI MEDICAL (NASDAQ: NARI): Kaplan Fox Encourages Inari Medical, Inc Investors with Significant Losses to Contact the Firm
    NEW YORK, NY - (NewMediaWire) - March 6, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)... 
    Via TheNewswire.com
    Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Inari Medical, Inc. (NARI)
    From Kirby McInerney LLP
    Via Business Wire
    INARI MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Inari Medical, Inc. on Behalf of Inari Medical Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    ROSEN, A LONGSTANDING LAW FIRM, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation – NARI
    From The Rosen Law Firm, P.A.
    Via Business Wire
    Inari Medical (NASDAQ: NARI): Kaplan Fox Investigates Potential Securities Fraud at Inari Medical
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Fraud
    Exposures Legal
    Inari Medical (NASDAQ: NARI): Kaplan Fox Investigates Potential Securities Fraud at Inari Medical
    NEW YORK, NY - (NewMediaWire) - February 29, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the... 
    Via TheNewswire.com
    Topics Fraud
    Exposures Legal
    Shoals Technologies Posts Weak Q4 Results, Joins Butterfly Network, Schrödinger And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    U.S. stock futures were lower this morning, with the Dow futures trading lower by over 100 points on Thursday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. 
    Via Benzinga
    Inari Medical Reports Fourth Quarter 2023 Financial Results
    From Inari Medical, Inc.
    Via GlobeNewswire
    Inari Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
    From Inari Medical, Inc.
    Via GlobeNewswire
    5 medical stocks growing earnings by triple digits
    There is a little known way to pick stocks like the pros do, and today's exercise points you to five high-probability winners in a sector that's quickly turning 
    Via MarketBeat
    Topics Economy
    Exposures Economy
    Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
    Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth. 
    Via Benzinga
    Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance
    From Inari Medical, Inc.
    Via GlobeNewswire
    Inari Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    From Inari Medical, Inc.
    Via GlobeNewswire
    Inari Medical Announces First Patient Enrollment in PEERLESS II Randomized Controlled Trial (RCT)
    Clinical study randomizing up to 1,200 patients designed to help change guidelines in treating intermediate-risk Pulmonary Embolism (PE) patients globally 
    From Inari Medical, Inc.
    Via GlobeNewswire
    Inari Medical Closes Acquisition of LimFlow
    From Inari Medical, Inc.
    Via GlobeNewswire
    After blowout earnings, Integer may be headed to new highs
    A growth strategy that includes both in-house expansion and acquisition activity could keep Integer Holdings Corporation's run going well into 2024. 
    Via MarketBeat
    Topics Economy
    Exposures Supply Chain
    Inari Medical to Present at Upcoming Investor Conferences
    From Inari Medical, Inc.
    Via GlobeNewswire
    Inari Medical Reports Third Quarter 2023 Financial Results
    From Inari Medical, Inc.
    Via GlobeNewswire
    Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders. 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.